Please login to the form below

Not currently logged in
Email:
Password:

IDF

This page shows the latest IDF news and features for those working in and with pharma, biotech and healthcare.

Roche preps new Kadcyla filings after phase 3 trial win

Roche preps new Kadcyla filings after phase 3 trial win

Says the drug significantly reduced IDFS in women with residual disease. ... In the KATHERINE study, giving Kadcyla (ado-trastuzumab emtansine) to women with residual disease despite pre-surgery (neoadjuvant) therapy significantly reduced invasive disease

Latest news

  • Diabetes puts economic growth at risk, says IDF Diabetes puts economic growth at risk, says IDF

    Comments come on World Diabetes Day. The increasing prevalence of diabetes in the world's richest nations is putting economic growth at risk, according to the International Diabetes Federation (IDF). ... According to the IDF, around 70% of type 2

  • Study highlights poor diabetes consultation Study highlights poor diabetes consultation

    The study was led by the diabetes-focused pharma company Novo Nordisk in collaboration with the International Diabetes Federation (IDF), the International Alliance of Patients' Organizations (IAPO), the Steno Diabetes Center ... IDF president Sir Michael

  • Survey to gauge impact of doctor-patient talks in diabetes Survey to gauge impact of doctor-patient talks in diabetes

    health. The survey - sponsored by Boehringer Ingelheim and Lilly and developed with the International Diabetes Federation (IDF) - will involve more than 10, 000 people with type 2 diabetes across 26 countries ... Being diagnosed with type 2 diabetes can

  • One in ten people could have diabetes by 2035 One in ten people could have diabetes by 2035

    Ten per cent of the world's population is expected to have diabetes by 2035, according to new figures from the International Diabetes Federation (IDF). ... The IDF also said it expects a 60 per cent increase in the number of people with diabetes in South

  • Lilly invests $700m in insulin manufacturing Lilly invests $700m in insulin manufacturing

    diabetes. This predicted increase in diabetes levels was confirmed yesterday on World Diabetes Day by the International Diabetes Federation (IDF), which published a revised Diabetes Atlas that forecasts that the number

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • The rising prevalence of diabetes in Europe The rising prevalence of diabetes in Europe

    No country in Europe has managed to prevent the diabetes epidemic from rising,” says João Nabais, president of IDF Europe. ... Over the summer IDF Europe took leadership of the Policy Action Network on Diabetes (ExPAND).

  • The Chinese diabetes challenge The Chinese diabetes challenge

    The JAMA study, which was conducted by the Chinese Society of Diabetes (CDS) together with the International Diabetes Federation (IDF), suggested that the annual cost to the Chinese national health service

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    It's no secret that one of the main healthcare issues affecting the entire world is the increasing prevalence of diabetes, with estimates from the International Diabetes Federation (IDF) suggesting that

  • Interview: Peter Meeus, Novo Nordisk Interview: Peter Meeus, Novo Nordisk

    These figures are only expected to get higher, as unhealthy diets and sedentary lifestyles become more common across the world, prompting former president of the International Diabetes Federation (IDF) Jean Claude

  • Interview: Pierre Chancel, Sanofi Diabetes Interview: Pierre Chancel, Sanofi Diabetes

    Meanwhile, Sanofi's '3C Study of Type 1 Diabetes in China' partnership with the International Diabetes Federation (IDF) continues to deliver evidence of the coverage, cost and care of type 1 ... As there is no formalised organisation for type 1 diabetes

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • IDF appoints new CEO IDF appoints new CEO

    Petra Wilson to head global diabetes organisation. The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its new CEO. ... IDF has a deservedly high reputation as a forthright advocate for people with diabetes, and I look forward to

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics